DA
BVS icon

Denali Advisors’s Bioventus BVS Stock Holding History

Denali Advisors’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,500
Closed -$25K – 425
2022
Q3 		$25K Hold
3,500
– – 0.01% 270
2022
Q2 		$24K Hold
3,500
– – 0.01% 287
2022
Q1 		$49K Hold
3,500
– – 0.02% 242
2021
Q4 		$51K Buy
+3,500
New +$49.8K 0.02% 247

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Denali Advisors's BVS Position: Q4 2022 in Review

Denali Advisors sold out of Bioventus (BVS) in Q4 2022, closing a stake of 3,500 shares — an estimated $25K sold.

Denali Advisors first reported a position in BVS in Q4 2021 and held it in 4 quarters. The position peaked at $51K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q4 2022.

  • Denali Advisors reported no remaining Bioventus position as of Q4 2022 after selling out during the quarter.
  • Denali Advisors sold 3,500 Bioventus shares in Q4 2022, an estimated $25K.
  • Denali Advisors first reported a position in Bioventus in Q4 2021 and held it in 4 quarters.
  • Denali Advisors's Bioventus position peaked at $51K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q4 2022.

Based on Denali Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.